New Labeling Required for Long-Acting Opioids: What Does it Mean for Clinicians?

With this change in language, the FDA seeks to narrow the range of patients for whom the long-acting/extended-release opioids are prescribed. Dr Steven King wonders which clinicians they hope to reach.
Source: Consultant Live - Category: Primary Care Source Type: news
More News: Primary Care